The pharmaceutical industry has always been associated with groundbreaking trials, discoveries, and innovation. However, this experimental work also exposes pharma companies to an exorbitant amount of risk. High risk areas include clinical-trials, product design & production, drug approval, product quality, and adherence to global commercial practices. These risks must be carefully monitored & addressed to prevent … Continued